Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
2
50%
Ph phase_4
2
50%

Phase Distribution

0

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
Phase 4Post-market surveillance
2(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Other(1)

Detailed Status

Completed3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (50.0%)
Phase 42 (50.0%)

Trials by Status

completed375%
unknown125%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_2

Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Respimat Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT02175342
unknownphase_4

4"S" - Seasonal Symptoms Suppression Study

NCT02557269
completedphase_2

NoAL (HPMC) in Combination With Oxymetazoline in Patients With Allergic Rhinitis

NCT01986582
completedphase_4

Effect of Arginine on Microcirculation in Patients With Diabetes

NCT00902616

Clinical Trials (4)

Showing 4 of 4 trials
NCT02175342Phase 2

Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Respimat Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Completed
NCT02557269Phase 4

4"S" - Seasonal Symptoms Suppression Study

Unknown
NCT01986582Phase 2

NoAL (HPMC) in Combination With Oxymetazoline in Patients With Allergic Rhinitis

Completed
NCT00902616Phase 4

Effect of Arginine on Microcirculation in Patients With Diabetes

Completed

All 4 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
4